HEALTH OF WOMAN. 2018.2(128):53–55; doi 10.15574/HW.2018.128.53
Sadigov Yu. M.
Shupyk National Medical Academy of Postgraduate Education, Kiev

The objective: to establish а role of an infectious pathogen in development hyperplastic processes of uterus.
Materials and methods. 250 women who were divided into five groups were surveyed.
Criteria of including in research: existence combined hyperplastic processes of uterus – two and more diseases (hyperplasia an endometrium, hysteromyoma and an adenomyosis), verified morphologically, fertilny age (25–45 years).
Results. It is established that patients with combination have hyperplasias an endometrium with hysteromyoma and signs of chronic inflammatory process in uterus tissues are available an adenomyosis. A becoming infected of tissues an endometrium and myometrium conditionally pathogenic microorganisms (21.7% of women with hyperplastic processes of uterus); prevalence them not only mucous, but also myocytes (at 26.9% – with hysteromyoma, 16.1% – hyperplasia an endometrium, 40% – with an adenomyosis). A high average caption of Mycoplasma hominis 6,12±0,19. Correlation of hyperplastic diseases of uterus with mutant strains of Mycoplasma hominis (r=+0.36; p=0.012).
Conclusion. The received results allow to survey infectious pathogens as cofactors of hyperplastic processes of uterus pathogenetically bound to representatives of flora of the bottom departments of а genital tract and participating in realization of inflammatory process.
Key words: hyperplastic processes of uterus, infectious pathogen.

REFERENCES

1. Dobrohotova YuE. 2016. Sovremennyie podhodyi k terapii giperplasticheskih protsessov endometriya. Effektivnaya farmakoterapiya: 24–30.

2. Kondrikov NI. 2015. Patologiya matki. M, Prakticheskaya meditsina:176.

3. Sidorova IS. 2017. Giperplasticheskie protsessyi endometriya: osobennosti kliniki i terapii. Vrach 3:40–42.

4. Chernuha GE. 2012. Giperplaziya endometriya: perspektivyi razvitiya problemyi. Akusherstvo i ginekologiya 4:11–16.

5. Amezcua СA. 2010. Apoptosis may be an early event of progestin therapy for endometrial hyperplasia. USA. Gynecol-Oncol. 79(2):169–176.

6. Buckley CH. 2012. Biopsy pathology of endomertiun. NY, Arnold: 126

7. Eckert LO. 2012. Endometrititis. The clinical-pathologic syndrome. Am. J. Obstet Gynecol. 186(4):690–5. https://doi.org/10.1067/mob.2002.121728